-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster III

Symposia: T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Junya Makiyama, MD, PhD1, Masahito Tokunaga, MD, PhD2*, Motoaki Shiratsuchi, MD, PhD3, Takanori Toyama, MD4*, Satoshi Oka, MD, PhD5*, Ilseung Choi, MD, PhD6, Takahiro Yoshida, PhD7*, Kiyoshi Okazuka, MD, PhD7* and Atae Utsunomiya, MD, PhD2

1Department of Hematology, Sasebo City General Hospital, Sasebo, Japan
2Department of Hematology, Imamura General Hospital, Kagoshima, Japan
3Department of Hematology, Iizuka Hospital, Iizuka, Japan
4Department of Internal Medicine, Miyazaki Prefectural Nobeoka Hospital, Nobeoka, Japan
5Department of Hematology and Blood Transfusion, Kochi Health Sciences Center, Kochi, Japan
6Department of Hematology and Cell therapy, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
7Japan Medical Affairs, Japan Oncology Business Unit, Takeda Pharmaceutical Company Limited, Tokyo, Japan

Ahmad Kiwan, MD1, Tariq Kewan, MD1, Carlos Bravo-Perez, MD2,3*, Valeria Visconte, PhD4, Carmelo Gurnari, MD, PhD5, Arda Durmaz, PhD6*, Alexa Siddon, M.D.7*, Stephanie Halene, MD8, Tarsheen Sethi, MD, MSc9, Jaroslaw Maciejewski10 and Francine M. Foss, MD11

1Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
2Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, University of Murcia, IMIB-Pascual Parrilla, CIBERER - Instituto de Salud Carlos III, Murcia, Spain
3Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
4Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Taussig Cancer Institute, Cleveland, OH
5Cleveland Clinic Foundation, Cleveland, OH
6Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, CLEVELAND, OH
7Section of Hematology, Department of Medicine, Yale University School of Medicine, New Haven, CT
8Yale Univ. School of Medicine, New Haven, CT
9Hematology, Yale University School of Medicine, New Haven, CT
10Taussig Cancer Center, Cleveland, OH
11Yale University School of Medicine, Hamden, CT

Bradley M. Haverkos, MD, MS, MPH1, Chunlan Chang, PhD2*, Robert Ristuccia, PhD2*, Yutong Chang, MS3*, Jennifer Friderici, MS3* and Sima Rozati, MD, PhD4*

1Division of Hematology, University of Colorado, Aurora, CO
2Kyowa Kirin Inc., Princeton, NJ
3KMK Consulting Inc., Morristown, NJ
4Johns Hopkins School of Medicine, Baltimore, MD

John C. Reneau, MD, PhD1, Ying Huang, MS, MA2, Walter Hanel, MD, PhD3, Jonathan E. Brammer2, Catherine Chung, MD4* and Basem M. William, MD, MRCP(UK), FACP5

1The James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
2Division of Hematology, The Ohio State University, Columbus, OH
3The James Cancer Center, The Ohio State University Wexner Medical Center, Dublin, OH
4The Ohio State University, Columbus, OH
5OhioHealth, Columbus, OH

Yuxi Li1,2*, Jingjing Yuan2,3*, Rui Cui2,4,5*, Ying Yu2,6*, Yanshan Huang4,7*, Yuting Yan, MD2,6*, Jingwen Sun1,2*, Tingyu Wang2*, Rui Lyu, MD1,2*, Xiong Wenjie, MD2,6*, Qi Wang, MD1,2*, Wei LIU2,8*, Gang An2,3*, Weiwei Sui, MD1,2*, Yan Xu2,9*, Wenyang Huang, MD1,2*, Dehui Zou2,3*, Fengkui Zhang2,4*, Huijun Wang2,9*, Lugui Qiu2,10 and Shuhua Yi2*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
2Tianjin Institutes of Health Science, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology Blood Diseases Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Tianjin, China
5Department of hematology, Tianjin First center hospital, Tianjin, China
6State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
7Tianjin Institutes of Health Science, Tianjin, China, Tianjin, China
8State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology Blood Diseases Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Tjianjin, China
9State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
10State Key Laboratory of Experimental Hematology National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Ahmad Kiwan, MD1, Tariq Kewan, MD1, Mina Xu, MD2*, Alexa Siddon, M.D.3*, Michael Girardi, MD4*, Tarsheen Sethi, MD, MSc5 and Francine M. Foss, MD6

1Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
2Yale University, New Haven, CT
3Section of Hematology, Department of Medicine, Yale University School of Medicine, New Haven, CT
4Department of Dermatology, Yale School of Medicine, New Haven, CT
5Hematology, Yale University School of Medicine, New Haven, CT
6Yale University School of Medicine, Hamden, CT

Basem M. William, MD, MRCP(UK), FACP and Yvonne A. Efebera, MD

Blood and Marrow Transplant and Cellular Therapy Program, OhioHealth, Columbus, OH

Haiwen Huang, MD1*, Mao Jin2*, Qisi Lu3*, Tao You3* and Jingxian Gu, M.D.4*

1The department of hematology, the First Affiliated Hospital of Soochow University,National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, SuZhou, China
2The First Affiliated Hospital of Soochow University, Suzhou, AL, China
3The First Affiliated Hospital of Soochow University, Suzhou, China
4Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China

John Yan, MD1*, Parth Patel, MD2*, Simran Arjani, MD3*, Eliot A Rapoport, MD4, Brittany Moavero5*, Jhannine Verceles6*, Angela Czavar5*, Emma Cordover7*, Julie Nguyen8, Kira Gritsman, MD, PhD9, Noah Kornblum, MD9, Aditi Shastri, MD10, Ioannis Mantzaris, MD9, Nishi Shah, MBBS, MPH6, Ridhi Gupta, MD6, Marina Konopleva11, Amit Verma, MBBS8*, Eric J. Feldman, MD9*, Dennis L Cooper, MD6, Mendel Goldfinger6*, R. Alejandro Sica, MD9 and Lauren Shapiro, MD9

1Department of Medicine, Montefiore Medical Center, East Brunswick, NJ
2Dept of Medicine, Montefiore Medical Center, Bronx, NY
3Department of Internal Medicine, Montefiore Medical Center, Bronx, NY
4Department of Medicine, Montefiore Medical Center, Bronx, NY
5Montefiore Medical Center, Bronx, NY
6Montefiore Einstein Comprehensive Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
7Montefiore Einstein Cancer Center, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY
8Albert Einstein College of Medicine, Bronx, NY
9Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
10Hematology/Oncology, Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY
11Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY

Thomas S Chan, FRCP, MBBS, MRCP1*, Yok-Lam Kwong, MD2*, Eric Tse, PhD, MBBS3, Tony Kwun Yat Wu, BSc, MBBS, MRCP, FHKCP, FHKAM3* and Cheong Ngai4*

1Queen Mary Hospital, Hong Kong, Hong Kong
2Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong
3Department of Medicine, The University of Hong Kong, Hong Kong, Hong Kong
4Queen Mary Hospital, Hong Kong, HKG

Jesca Boot1*, Elizabeth Nelmes1*, Findlay Bewicke-Copley1*, Krushika Paleja2*, Emily Davenport3*, Ross Henderson, MD4*, William Hann, MB BChir1*, Xiao-Yin Zhang, BMBCh, MA, PhD5*, Hannah Bielby6*, Harshita Goradia7*, Naim Rahimi8*, Amjad Hmaid9*, Rumman Fatima Nizam9*, Imogen Welding10*, Vivek Radhakrishnan11*, Callum Harris12*, Danielle Monteil, MBBS13*, Andrew Clear1*, Maria Calaminici1*, Paul Greaves9*, Andrew J. Davies, MD, PhD14*, Graham P. Collins5, Matthew R Wilson4*, Jeffery Smith, MBChB BMedSci MRCP FRCPath13*, Christopher P Fox, PhD15, Wendy Osborne, MD6*, Lucy Cook, MD, MBBS, PhD, BSc, MB3*, Matthew Ahearne2*, Kate Cwynarski, MBBS, PhD, FRCP, FRCPath10*, John G. Gribben, MD1 and Jessica Okosun, MB BChir PhD1

1Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
2University Hospitals Leicester NHS Trust, Leicester, United Kingdom
3Imperial College Healthcare NHS Trust, London, United Kingdom
4Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
5Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
6Newcastle Hospitals NHS Trust, Newcastle Upon Tyne, United Kingdom
7Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
8Royal Berkshire NHS Trust, Reading, United Kingdom
9Barking, Havering and Redbridge University Hospital NHS Trust, Romford, United Kingdom
10University College London Hospitals NHS Foundation Trust, London, United Kingdom
11University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
12Buckinghamshire NHS Trust, Buckinghamshire, United Kingdom
13The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdom
14Southampton CRUK/NIHR Experimental Cancer Medicines Centre, University of Southampton, Southampton, United Kingdom
15School of Medicine, University of Nottingham, Nottingham, United Kingdom

Alexander Kaminsky, BS1*, Lauren M. Fahmy, BS1, Zaid Bilgrami, MD2*, Hye Ryung Yang, MD3*, Volkan Beylergil, MD4*, Mengxi Zhou, MS2*, Antonio T. Fojo, MD, PhD2*, Susan E. Bates, MD2*, Lawrence Schwartz, MD3* and Larisa J Geskin, MD5*

1Columbia University Vagelos College of Physicians and Surgeons, New York, NY
2Columbia University Irving Medical Center, Columbia University, New York, NY
3Memorial Sloan Kettering Cancer Center, New York, NY
4Columbia University Irving Medical Center, New York, NY
5Department of Dermatology, Columbia University Irving Medical Center, New York, NY

Xingtong Wang, MD/PhD, Wei Guo, MD/PhD*, Yangzhi Zhao, MD/PhD*, Jia Li and Ou Bai, MD/PhD*

Department of Hematology, The First Hospital of Jilin University, Changchun, China

Rong Tao, MD, PhD1*, Chuanxu Liu, MD, PhD1*, Yan Gao, M.D, PhD2*, Yang Yu3*, Zhi Guo3*, Jun Zhao3* and Huiqiang Huang, M.D, PhD2

1Fudan University Shanghai Cancer Center, Shanghai, China
2Sun Yat-Sen University Cancer Center, Guangzhou, China
3Antengene Therapeutics Ltd., Shanghai, China

Swaminathan P Iyer, MD1*, Ranjit Nair, MD2, Neha Mehta-Shah, MD3, Don A. Stevens, MD4, Alessandra Tucci, MD5, Antonio Pinto6* and Pier Luigi Zinzani, MD7,8

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2The University of Texas MD Anderson Cancer Center, Houston, TX
3Siteman Cancer Center, Washington University School of Medicine, Olivette, MO
4Norton Cancer Institute St. Mathew's, Louisville, KY
5Hematology, ASST Spedali Civili, Brescia, Italy
6Hematology-Oncology and Stem Cell Transplantation Unit, Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, IRCCS, Naples, Italy
7Institute of Hematology “L. e A. Seràgnoli”, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
8University of Bologna, Istituto Di Ematologia, Bologna, Italy

Qingqing Cai, PhD1, Yi Xia, M.D, PhD1*, Liang Wang2*, Dongfeng Zeng3*, Hongyan Tong4, Huiqiang Huang, M.D, PhD1, Yuerong Shuang5*, Zhigang Peng6*, Ying Zhao7*, Xiaobo Wang8*, Xiuhua Sun8*, Yu Yang9*, Daoguang Chen9*, Zhenya Hong10*, Jinni Wang, M.D, PhD1*, Jun Cai, M.D, PhD1*, Wei Zhang11*, Rong Tao12*, Hong Cen13*, Jianzhen Shen14*, Yirong Jiang15*, Yan Gao, M.D, PhD1*, Xiaojie Fang, M.M1*, Man Nie, M.D, PhD1*, Xuanye Zhang, M.D, PhD1*, Bing Bai, M.D, PhD1*, Yuchen Zhang, M.D, PhD1*, Qihua Zou, M.D, PhD1*, Xi Li3*, Chunmei Yang4*, Xin Gao8* and Hao Xu10*

1Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
2Beijing Tongren Hospital, Beijing, China
3Chinese People's Liberation Army, Army Medical Center, Chongqing, China
4The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
5Jiangxi Cancer Hospital, Nanchang, China
6The First Affiliated Hospital of Guangxi Medical University, Nanning, China
7The First People's Hospital of Foshan, Foshan, China
8The Second Hospital of Dalian Medical University, Dalian, China
9Fujian Provincial Cancer Hospital, The Affiliated Tumor Hospital of Fujian Medical University, Fuzhou, China
10Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
11Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
12Fudan University Shanghai Cancer Center, Shanghai, China
13Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China
14Fujian Medical University Union Hospital, Fuzhou, China
15Dongguan Hospital Affiliated to Southern Medical University, Dongguan, China

Benedetta Sordi, MD1*, Ozgur Can Eren, MD2*, Nivetha Ganesan, MPH3*, Varun Iyengar, MD4, Robert Stuver, MD4, William T. Johnson, DO5, Alison Moskowitz, MD4, Paola Ghione, MD, MSEpi3, Natasha Galasso3*, Ellie Casper, MS, DPT4*, Tiffany Chang, MS3*, Helen Hancock, ANP3*, Theresa Davey, MMSc, PA-C3*, Alexander P. Boardman, MD4*, Philip Caron, MD4, Kevin A. David, MD4*, Lorenzo Falchi, MD3, Paul A. Hamlin, MD4, Andrew M. Intlekofer, MD, PhD4, Anita Kumar, MD6, Efrat Luttwak, MD4, Ariela Noy, MD7, Colette Owens, MD4, Maria Lia Palomba, MD4, Gilles Salles, MD, PhD8, Raphael E. Steiner, MD3, Pallawi Torka, MD4, Santosha A. Vardhana, MD, PhD4, Ahmet Dogan, MD, PhD3, Steven Horwitz, MD4 and Zachary D. Epstein-Peterson, MD4

1Department of Hematology Careggi University Hospital, Florence, Italy
2Hematopathology Service, Department of Pathology and Laboratory Medicine Memorial Sloan Kettering Cancer Center, New York City, NY
3Memorial Sloan Kettering Cancer Center, New York, NY
4Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
6Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
7Memorial Sloan-Kettering Cancer Ctr., New York, NY
8Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY

Fabiola Valvert, MD, PhD1,2, Omar Eduardo Fernandez Vargas, MD, MSc3*, Sally Paredes, MD4*, Luís Alberto de Pádua Covas Lage, MD, PhD5*, Luis Mario Villela Martinez, MD, MSc6,7*, Jose Marcial Macias Abasto8,9*, Victoria Irigoin, MD10*, Cesar Camilo Carias Alvado, BS11*, Juan C Barrios12*, Brenda Lizeth Acosta Maldonado, MSc13,14*, Denisse Castro, MD4, Betty Ramos Condori15,16*, Juliana Pereira, MD, PhD17, Silvia Rivas-Vera, MD18*, Brady Beltran, MD4* and Luis Malpica, MD19*

1Department of Hematology, Hospital Bonanova, Guatemala City, Guatemala
2Escuela de Estudios de Postgrado, Facultad de Ciencias Médicas, Universidad de San Carlos de Guatemala, Guatemala City, Guatemala
3National Cancer Institute, Mexico City, EM, Mexico
4Hospital Edgardo Rebagliati Martins, Lima, Peru
5Department of Hematology, University of Sao Paulo, Sao Paulo, Brazil
6Hospital Fernando Ocaranza, Hermosillo, Mexico
7Centro Medico Dr. Ignacio Chavez, Hermosillo, Sonora, MEX
8Facultad de Medicina UMSS, Clinica Los Olivos, Cochabamba, Bolivia (Plurinational State of)
9Caja Petrolera de Salud, Cochabamba, Bolivia (Plurinational State of)
10Bone marrow transplant unit, British Hospital, Montevideo, Uruguay
11La Liga Nacional Contra El CáNcer De Guatemala Y El Instituto De Cancerol, Ciudad De Guatemala, GTM
12Departamento de Biología Molecular, Liga Nacional Contra el Cancer, Instituto de Cancerología de Guatemala, Guatemala City, Guatemala
13Agrupación Mexicana para el Estudio de la Hematología, Ciudad de Mexico, Mexico
14Departament of Hematology, Institute National of Cancerology, Mexico, DF, Mexico
15Department of Hematology, Hospital de Clínicas Universitario La Paz, La Paz, Bolivia (Plurinational State of)
16Facultad de Medicina, Universidad Mayor de San Andrés, La Paz, Bolivia (Plurinational State of)
17University of São Paulo, Department of Hematology, Hemotherapy & Cell Therapy, University of São Paulo, São Paulo, São Paulo, Brazil
18Departament of Hematology, Instituto Nacional Cancerologia, Mexico City, MEX
19Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Josie G Ford, BSc1, Sean M McCabe, BS1*, Alexandra W Lenart, BA1*, Mark N Sorial, PharmD, RPh2*, Mwanasha H. Merrill, MD3, Anna B Rider, BSc4*, Aliyah R. Sohani, MD5,6*, Ronald A Nemec, BA1*, Kusha Chopra, BA1*, Caroline MacVicar, BA1*, Eric D. Jacobsen, MD7 and Salvia Jain, MD1,6,8

1Department of Medicine, Massachusetts General Hospital, Boston, MA
2Department of Pharmacy, Massachusetts General Hospital Cancer Center, Boston, MA
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Department of Pathology, Massachusetts General Hospital, Boston, MA
5Department of Pathology, Maasachusetts General Hospital, Boston, MA
6Harvard Medical School, Boston, MA
7Dana-Farber Cancer Institute, Boston, MA
8Broad Institute of Harvard and MIT, Cambridge, MA

*signifies non-member of ASH